Michael Boyiadzis | Akateeminen Kirjakauppa

Haullasi löytyi yhteensä 5 tuotetta
Haluatko tarkentaa hakukriteerejä?

HEMATOLOGY - ONCOLOGY THERAPY

Tekijä: Michael Boyiadzis; Peter Lebowitz; James Frame; Tito Fojo
Kustantaja: McGraw-Hill Education / Medical (2007)
Saatavuus: Ei tiedossa

EUR 80,60

HEMATOLOGY - ONCOLOGY THERAPY

Tekijä: Michael Boyiadzis; James Frame; David Kohler; Tito Fojo
Kustantaja: McGraw Hill / Medical (2014)
Saatavuus: Loppuunmyyty.

EUR 188,80

CANCER IMMUNOTHERAPY IN CLINICAL PRACTICE: PRINCIPLES AND PRACTICE

Tekijä: Michael Boyiadzis; John M. Kirkwood; Theresa L. Whiteside
Kustantaja: McGraw Hill / Medical (2026)
Saatavuus: Ei tiedossa

EUR 152,10

HEMATOLOGY-ONCOLOGY THERAPY, THIRD EDITION

Tekijä: Michael Boyiadzis; Tito Fojo
Kustantaja: McGraw Hill / Medical (2022)
Saatavuus: Noin 16-19 arkipäivää

EUR 276,00

RADIATION-ONCOLOGY THERAPY

Tekijä: Sushil Beriwal; M. Saiful Huq; Scott Glaser; Michael Boyiadzis
Kustantaja: McGraw Hill / Medical (2024)
Saatavuus: Ei tiedossa

EUR 253,70

Hematology - Oncology Therapy

Michael Boyiadzis, Peter Lebowitz, James Frame, Tito Fojo

80,60 €

McGraw-Hill Education / Medical
Asu: Pehmeäkantinen kirja
Julkaisuvuosi: 2007, 16.09.2006 (lisätietoa)
Kieli: Englanti

The first clinical manual to bridge the disciplines of hematology and oncology

A Doody's Core Title!

Hematology-Oncology Therapy integrates an extensive amount of information ( 67 chapters ) that is critical to both office- and hospital-based clinical practice of hematology and oncology. This comprehensive approach makes the book invaluable to all practitioners involved in the care of patients with cancer or hematologic diseases.

The three sections of Hematology-Oncology Therapy are:

Oncology
Supportive Care, Drug Preparation, Complications, and Screening
Selected Hematologic Diseases

Section I provides detailed information about the administration, emetogenic potential, toxicity, dose modification, monitoring, and efficacy of commonly used and recently approved chemotherapeutic regimens or drugs and biological agents. In addition, each chapter, focused on a specific cancer, contains information about epidemiology, pathology, work-up, and staging, as well as survival data.

Section II consists of topics commonly encountered in clinical hematology-oncology practice.

Section III provides an authoritative guide to therapy for the principal diseases in consultative hematology.

LISÄÄ OSTOSKORIIN

Kirjan painos kustantajalta loppu. Mahdollisesta uudesta painoksesta ei vielä tietoa. Seuraa saatavuutta.

Myymäläsaatavuus